FDA Drug · D-0789-2022

Losartan Potassium Tab. USP 50mg, Pkg Size: 30, Mfg: Lupin Pharmaceuticals, Inc., Preferred Pharmaceuticals, Inc.

Class II · Terminated

CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.

Affected lots / codes — check yours against thisLot: E1321O, Exp.: 5/31/2023 Lot: E2521H, Exp.: 5/31/2023 Lot: E2621F, Exp.: 5/31/2023

Recalling firm: Preferred Pharmaceuticals, Inc., Anaheim, CA
Classification: Class II (temporary or reversible harm possible)
Status: Terminated
Quantity: 44 Bottles of 90 Tablets 33 Bottles of 30 Tablets
Distribution: Nationwide within the U.S to CA, IN and FL.
Recall initiated: April 12, 2022
Classified: April 26, 2022
Terminated: September 22, 2022
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0789-2022%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

See every recall for this brand: Is Preferred Pharmaceuticals, Inc. recalled? →

Check this brand across all 8 databases →